Purple Biotech shares are trading lower by 11.5% during Monday's session. The company announced the exercise of warrants for $2 million gross proceeds. Unlock your all-in-one trading dashboard with ...

Have you ever considered trading biotech stocks? The biotech sector has a reputation for offering risky, but potentially extremely lucrative investing opportunities in relatively short time periods.

AT A GLANCE · Six new contracts offer futures market participants access to tools tracking some of the most popular S&P and ...

Woods noted that Biogen has multiple focuses across autoimmune kidney diseases and Alzheimer’s, unlike many names in the ...

Why do CEOs talk like that? Do biotech stock tips make good gifts? And what do Anthony Fauci and Stéphane Bancel have in common? We cover all that and more this week on “The Readout LOUD,” STAT’s ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Here's a peek at a few of the choices from the screener. Overview: Nanjing Vazyme Biotech Co., Ltd provides technology solutions in life science, biomedicine, and in vitro diagnostics, with a market ...

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update. Trading of Shanghai Henlius Biotech, Inc.’s H shares has been temporarily halted as of 9:00 a.m. on May 23, 2024, in ...

In interviews as well as a panel at BIO’s annual meeting, investors and life sciences bankers predicted an acceleration in ...

Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the ...

Abivax has been seen as a prime takeover target, with rumours claiming that several Big Pharma companies are keen to acquire ...